Acquired resistance to penicillin-β-lactamase inhibitor combinations in Escherichia coli is due to: (i) penicillinase hyperproduction due to the presence of the bla TEM-1 gene in small multicopy plasmids or strong promoters; (ii) overproduction of constitutive AmpC cephalosporinase; and (iii) OXA-type and inhibitor-resistant TEM (IRT) β-lactamases. IRT enzymes emerge via mutational events from TEM-1 or TEM-2 β-lactamases that affect substrate affinity for β-lactamase inhibitors. They are mainly isolated in urinary infections from community patients. Prevalence is variable, depending on geographical area, detection methods and potential selection pressure. These enzymes may evolve into complex mutants (CMT enzymes), which also confer resistance to extended-spectrum cephalosporins. CTX-M enzymes with the IRT phenotype have not been detected to date. New studies of IRT enzymes, including population structure, association with virulence traits and plasmid dispersion, are needed. © 2008 The Authors Journal Compilation © 2008 European Society of Clinical Microbiology and Infectious Diseases.
CITATION STYLE
Cantón, R., Morosini, M. I., Martin, O., De La Maza, S., & De La Pedrosa, E. G. G. (2008). IRT and CMT β-lactamases and inhibitor resistance. Clinical Microbiology and Infection. Blackwell Publishing Ltd. https://doi.org/10.1111/j.1469-0691.2007.01849.x
Mendeley helps you to discover research relevant for your work.